Patients were either insulin nave (approximately 60%) and had failed to achieve adequate glycemic control on at least 2 OAMs, or were already on another insulin glargine product, 100 units/mL, or a non-U.S.-licensed insulin glargine, 100 units/mL, along with at least 2 OAMs with adequate or inadequate glycemic control (approximately 40%)
The goal is reaching 2.4 mg, but not everyone gets there
Nutrients 13:3230 Wang J, Ren Z, Xu Y, Meydani SN and Wu D (2011) Dietary Epigallocatechin3gallate (EGCG) supplementation reduces clinical symptoms and pathology associated with experimental autoimmune encephalomyelitis (EAE) in mice via altered balance among CD4+ T cell subsets
Masaldan, S
1,2 By specifically binding to the key hormone GLP-1, it regulates blood glucose levels and lipid metabolism